Resumen de acción SHL
Siemens Healthineers AG, a través de sus filiales, desarrolla, fabrica y vende una gama de productos y servicios diagnósticos y terapéuticos a proveedores de asistencia sanitaria de todo el mundo. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 5/6 |
| Salud financiera | 2/6 |
| Dividendos | 3/6 |
Competidores de Siemens Healthineers AG
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | €49.80 |
| Máximo en las últimas 52 semanas | €58.14 |
| Mínimo de 52 semanas | €47.31 |
| Beta | 0.73 |
| 1Cambio en 1 mes | -2.96% |
| Variación en 3 meses | -2.62% |
| Cambio de 1 año | -3.26% |
| 3Variación en 3 años | -21.57% |
| Variación en 5 años | 13.13% |
| Variación desde la OPV | 64.90% |
Noticias y actualizaciones recientes
Siemens Healthineers AG (ETR:SHL) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Nov 10
Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Recent updates
Siemens Healthineers AG (ETR:SHL) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Nov 10Earnings Tell The Story For Siemens Healthineers AG (ETR:SHL)
Oct 21Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Rentabilidad de los accionistas
| SHL | DE Medical Equipment | Mercado DE | |
|---|---|---|---|
| 7D | -0.8% | -1.0% | -0.02% |
| 1Y | -3.3% | -7.3% | 8.2% |
Rentabilidad vs. Industria: SHL superó a la industria German Medical Equipment, que obtuvo un rendimiento del -7.3% el año pasado.
Rentabilidad vs. Mercado: SHL obtuvo unos resultados inferiores a los del mercado German, que fueron del 8.2% el año pasado.
Volatilidad de los precios
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Precio estable de las acciones: SHL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de SHL (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | 72,300 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, a través de sus filiales, desarrolla, fabrica y vende una gama de productos y servicios diagnósticos y terapéuticos a proveedores de asistencia sanitaria de todo el mundo. Opera a través de cuatro segmentos: Imaging, Diagnostics, Varian y Advanced Therapies. El segmento de imagen ofrece sistemas de resonancia magnética, tomografía computarizada, rayos X, imagen molecular y ultrasonidos.
Resumen de fundamentos de Siemens Healthineers AG
| Estadísticas fundamentales de SHL | |
|---|---|
| Capitalización bursátil | €55.57b |
| Beneficios(TTM) | €1.94b |
| Ingresos (TTM) | €22.36b |
28.6x
Ratio precio-beneficio (PE)2.5x
Ratio precio-ventas (PS)¿Está SHL sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SHL | |
|---|---|
| Ingresos | €22.36b |
| Coste de los ingresos | €13.90b |
| Beneficio bruto | €8.47b |
| Otros gastos | €6.53b |
| Beneficios | €1.94b |
Últimos beneficios comunicados
Sep 30, 2024
Próxima fecha de beneficios
Nov 26, 2024
| Beneficios por acción (BPA) | 1.74 |
| Margen bruto | 37.87% |
| Margen de beneficio neto | 8.68% |
| Ratio deuda/patrimonio | 89.0% |
¿Cómo se ha desempeñado SHL a largo plazo?
Ver rendimiento histórico y comparativa